Skip to main content
. 2009 Nov 1;9(17):1–42.
Quality assessment Summary of findings Importance
No of patients Effect Quality
No of studies Design Limitations Inconsistency Indirectness Imprecision Other Specialized Multidiscip.
Care
Usual Care Relative (95% CI) Absolute
All Cause Mortality
8 RCTs no serious
limitations
no serious
inconsistency
serious no serious
imprecision
none 223/1453
(15.3%)
259/1344
(19.3%)
RR 0.71
(0.56 to 0.91)
56 fewer per 1000
(from 17 fewer to 85 fewer)
⊕⊕⊕Ο
MODERATE
CRITICAL
All Cause Mortality Direct Team Care
6 RCTs no serious
limitations
no serious
inconsistency
serious1 no serious
imprecision
none 94/617
(15.2%)
126/511 (24.7%) RR 0.60 (0.47 to 0.76) 99 fewer per 1000 (from 59 fewer to 131 fewer) ⊕⊕⊕Ο
MODERATE
CRITICAL
All Cause Mortality Indirect Team Care
2 RCTs no serious
limitations
no serious
inconsistency
serious2 serious3 none 129/836 (15.4%) 133/833 (16%) RR 0.97 (0.77 to 1.21) 5 fewer per 1000 (from 37 fewer to 34 more) ⊕⊕ΟΟ
LOW
CRITICAL
All Cause Mortality SMCC vs. PCP
6 RCTs no serious
limitations
no serious
inconsistency
serious4 no serious
imprecision
none 95/575
(16.5%)
114/464
(24.6%)
RR 0.65
(0.51 to 0.84)
86 fewer per 1000 (from 39 fewer to 120 fewer) ⊕⊕⊕Ο
MODERATE
CRITICAL
All Cause mortality SMCC vs. Cardiologist
2 RCTs no serious
limitations
no serious
inconsistency
serious5 serious6 none 128/878
(14.6%)
145/880
(16.5%)
RR 0.78
(0.46 to 1.32)
36 fewer per 1000 (from 89 fewer to 53 more) ⊕⊕ΟΟ
LOW
CRITICAL
HF-Specific Mortality
3 RCTs no serious
limitations
no serious
inconsistency
serious7 no serious
imprecision
none 195/892
(21.9%)
258/892
(28.9%)
RR 0.58
(0.32 to 1.05)
121 fewer per 1000 (from 197 fewer to 14 more) ⊕⊕⊕Ο
MODERATE
IMPORTANT
HF-Specific Mortality Direct Team Care
2 RCTs no serious
limitations
no serious
inconsistency
serious8 serious9 none 12/132
(9.1%)
30/134
(22.4%)
RR 0.42
(0.21 to 0.83)
130 fewer per 1000 (from 38 fewer to 177 fewer) ⊕⊕ΟΟ
LOW
IMPORTANT
HF-Specific Mortality Indirect Team Care
1 RCTs no serious
limitations
no serious
inconsistency
serious10 serious11 none 183/760
(24.1%)
228/758
(30.1%)
RR 0.80
(0.68 to 0.95)
60 fewer per 1000 (from 15 fewer to 96 fewer) ⊕⊕ΟΟ
LOW
IMPORTANT
HF-Specific Mortality SMCC vs. PCP
2 RCTs no serious
limitations
no serious
inconsistency
serious8 serious9 none 12/132
(9.1%)
30/134
(22.4%)
RR 0.42
(0.21 to 0.83)
130 fewer per 1000 (from 38 fewer to 177 fewer) ⊕⊕ΟΟ
LOW
IMPORTANT
HF-Specific Mortality SMCC vs. Cardiologist
1 RCTs no serious limitations no serious inconsistency serious10 serious11 none 183/760
(24.1%)
228/758
(30.1%)
RR 0.80
(0.68 to 0.95)
60 fewer per 1000 (from 15 fewer to 96 fewer) ⊕⊕ΟΟ
LOW
IMPORTANT
All Cause Hospitalization
7 RCTS no serious
limitations
serious12 serious13 no serious
imprecision
none 527/1175
(44.9%)
564/1222
(46.2%)
RR 1.12
(0.92 to 1.35)
55 more per 1000 (from 37 fewer to 162 more) ⊕⊕ΟΟ
LOW
IMPORTANT
All Cause Hospitalization Direct Team Care
5 RCTs no serious
limitations
serious14 serious15 no serious
imprecision
none 194/287
(67.6%)
193/335
(57.6%)
RR 1.31
(0.94 to 1.82)
179 more per 1000 (from 35 fewer to 472 more) ⊕⊕ΟΟ
LOW
IMPORTANT
All Cause Hospitalization Indirect Team Care
2 RCTs no serious
limitations
no serious
inconsistency
serious16 no serious
imprecision
none 311/836
(37.2%)
351/833
(42.1%)
RR 0.88
(0.79 to 0.99)
51 fewer per 1000 (from 4 fewer to 88 fewer) ⊕⊕⊕Ο
MODERATE
IMPORTANT
All Cause Hospitalization SMCC vs. PCP
6 RCTs no serious
limitations
serious17 serious18 no serious
imprecision
none 266/415
(64.1%)
268/464
(57.8%)
RR 1.19
(0.94 to 1.49)
110 more per 1000 (from 35 fewer to 283 more) ⊕⊕ΟΟ
LOW
IMPORTANT
All Cause Hospitalization SMCC vs. Cardiologist
1 RCTs no serious
limitations
no serious
inconsistency
serious10 serious11 none 261/760
(34.3%)
296/758
(39.1%)
RR 0.88
(0.77 to 1)
47 fewer per 1000 (from 90 fewer to 0 more) ⊕⊕ΟΟ
LOW
IMPORTANT
HF-Specific Hospitalization
6 RCTs no serious
limitations
serious19 serious20 no serious
imprecision
none 216/1197
(18%)
266/1185
(22.4%)
RR 0.86 (0.62 to 1.19) 31 fewer per 1000 (from 85 fewer to 43 more) ⊕⊕ΟΟ
LOW
IMPORTANT
HF-Specific Hospitalization Direct Team care
4 RCTs no serious
limitations
serious21 serious20 no serious
imprecision
none 61/361
(16.9%)
60/352
(17%)
RR 1.07
(0.52 to 2.19)
12 more per 1000 (from 82 fewer to 203 more) ⊕⊕ΟΟ
LOW
IMPORTANT
HF-Specific Hospitalization Indirect Team Care
2 RCTs no serious
limitations
no serious
inconsistency
serious16 no serious
imprecision
none 156/836
(18.7%)
206/833
(24.7%)
RR 0.75
(0.62 to 0.9)
62 fewer per 1000 (from 25 fewer to 94 fewer) ⊕⊕⊕Ο
MODERATE
IMPORTANT
HF-Specific Hospitalization SMCC vs. PCP
4 RCTs no serious
limitations
no serious
inconsistency22
serious23 no serious
imprecision
none 64/315
(20.3%)
86/305
(28.2%)
RR 0.73
(0.55 to 0.96)
76 fewer per 1000 (from 11 fewer to 127 fewer) ⊕⊕⊕Ο
MODERATE
IMPORTANT
HF-Specific Hospitalization SMCC vs. Cardiologist
2 RCTs no serious
limitations
serious24 serious25 serious26 none 152/882
(17.2%)
180/880
(20.5%)
RR 1.22
(0.43 to 3.45)
45 more per 1000 (from 117 fewer to 501 more) ⊕ΟΟΟ
VERY LOW
IMPORTANT
1

1 study completed in New Zealand, 1 in Netherlands, 2 in Sweden, 1 in the United Kingdom and 1 study in Poland

2

1 study completed in Argentina and 1 study completed in the USA

3

Predominately one large study contributing to the estimate of effect

4

2 studies completed in Sweden, 1 in New Zealand, 1 in the United Kingdom, 1 in Poland and 1 in the USA

5

1 study completed in The Netherlands and 1 in Argentina

6

1 large study contributing 77% to the estimate of the effect

7

1 study from Argentina, 1 from Sweden, and one from Poland

8

1 study from Poland and one from Sweden

9

Sample size of both studies small

10

Study completed in Argentina

11

Only 1 study contributing to estimate of effect

12

Inconsistency in direction of effect, confidence intervals do not over lap, magnitude of effect ranges from RR of 0.90 to 2.01

13

Studies completed in New Zealand, USA, Argentina, 2 in Sweden, UK, and Poland

14

Studies vary in direction of effect and magnitude of effect ranges from a RR of 1.01 to 2.01, confidence intervals do not overlap

15

Studies completed in New Zealand, Sweden, UK and Poland

16

Studies completed in Argentina and USA

17

Estimates of effect vary in direction, size and confidence intervals do not overlap

18

Studies from New Zealand, USA, Sweden (2), UK and Poland

19

Studies vary in size and direction of effect. RR ranges from 0.52 to 2.18

20

Studies from The Netherlands, New Zealand, USA, Argentina, UK and Poland

21

Inconsistency in magnitude and direction of effect. RR ranges from 0.52 to 2.67

22

This evidence was not downgraded for inconsistency because there was only one small study contributing to 2.8% of effect size with a RR of 2.69, which is opposite in direction and magnitude of effect to the other 3 studies in the evidence profile.

23

Studies from Poland, UK, US and New Zealand

24

Magnitude and direction of studies differ, confidence intervals do not overlap

25

Studies completed in The Netherlands and Argentina

26

One large study contributing approximately 73% to the effect size